Dr. Clement joined the LSU faculty in 2018 following the completion of her Internal Medicine and Infectious Diseases training at Duke University. Her academic interest lies in the prevention of HIV and sexually transmitted infections (STIs) in vulnerable populations, including racial/ethnic and gender minority populations in the South, with a particular focus on how to reduce the burden of HIV infection by maximizing the impact of pre-exposure prophylaxis (PrEP). She has been involved in PrEP related research since 2014 and served as the medical monitor for the HPTN 083 trial since 2018. Her NIH funded grants focus on determining methods to enhance PrEP uptake, particularly in the Deep South.
